PCSK9 and Calcific Aortic Valve Stenosis
暂无分享,去创建一个
[1] Y. Bossé,et al. Genetic and In Vitro Inhibition of PCSK9 and Calcific Aortic Valve Stenosis , 2020, JACC. Basic to translational science.
[2] B. Lewis,et al. An Exploratory Analysis of Proprotein Convertase Subtilisin/Kexin Type 9 Inhibition and Aortic Stenosis in the FOURIER Trial. , 2020, JAMA cardiology.
[3] J. Mehta,et al. PCSK9 and inflammation: Role of shear stress, pro-inflammatory cytokines and LOX-1 4. , 2019, Cardiovascular research.
[4] Frank D. Russo,et al. WHY STEAL FROM ONE WHEN YOU CAN STEAL FROM TWO: A UNIQUE CASE OF CLASSIC SUBCLAVIAN STEAL SYNDROME WITH CONCOMITANT CORONARY SUBCLAVIAN STEAL SYNDROME IN THE POST CORONARY BYPASS PATIENT , 2019, Journal of the American College of Cardiology.
[5] M. Koschinsky,et al. Lipoprotein(a) and Oxidized Phospholipids Promote Valve Calcification in Patients With Aortic Stenosis , 2019, Journal of the American College of Cardiology.
[6] N. Ferri,et al. PCSK9 Involvement in Aortic Valve Calcification. , 2018, Journal of the American College of Cardiology.
[7] C. Otto,et al. Calcific aortic stenosis , 2016, Nature Reviews Disease Primers.
[8] M. Weyant,et al. ox-LDL induces PiT-1 expression in human aortic valve interstitial cells. , 2013, Journal of Surgical Research.
[9] R. Prescott,et al. A randomized trial of intensive lipid-lowering therapy in calcific aortic stenosis. , 2005, The New England journal of medicine.